nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Vismodegib—skin cancer	0.148	0.202	CbGbCtD
Dolasetron—CYP3A4—Imiquimod—skin cancer	0.124	0.169	CbGbCtD
Dolasetron—CYP3A4—Temozolomide—skin cancer	0.124	0.169	CbGbCtD
Dolasetron—CYP2D6—Vemurafenib—skin cancer	0.107	0.146	CbGbCtD
Dolasetron—CYP3A4—Vismodegib—skin cancer	0.0862	0.117	CbGbCtD
Dolasetron—CYP3A4—Vemurafenib—skin cancer	0.0681	0.0928	CbGbCtD
Dolasetron—CYP2C9—Fluorouracil—skin cancer	0.0526	0.0717	CbGbCtD
Dolasetron—CYP3A4—Docetaxel—skin cancer	0.0234	0.0318	CbGbCtD
Dolasetron—Abdominal distension—Temozolomide—skin cancer	0.000831	0.00312	CcSEcCtD
Dolasetron—Hypertension—Imiquimod—skin cancer	0.000828	0.00312	CcSEcCtD
Dolasetron—Ataxia—Fluorouracil—skin cancer	0.000827	0.00311	CcSEcCtD
Dolasetron—Pneumonia—Dactinomycin—skin cancer	0.000818	0.00308	CcSEcCtD
Dolasetron—Chest pain—Imiquimod—skin cancer	0.000817	0.00307	CcSEcCtD
Dolasetron—Myalgia—Imiquimod—skin cancer	0.000817	0.00307	CcSEcCtD
Dolasetron—Arthralgia—Imiquimod—skin cancer	0.000817	0.00307	CcSEcCtD
Dolasetron—Anxiety—Imiquimod—skin cancer	0.000814	0.00306	CcSEcCtD
Dolasetron—Discomfort—Imiquimod—skin cancer	0.000807	0.00304	CcSEcCtD
Dolasetron—Sweating increased—Temozolomide—skin cancer	0.000804	0.00302	CcSEcCtD
Dolasetron—Dry mouth—Imiquimod—skin cancer	0.000799	0.00301	CcSEcCtD
Dolasetron—Decreased appetite—Vemurafenib—skin cancer	0.000798	0.003	CcSEcCtD
Dolasetron—Stomatitis—Dactinomycin—skin cancer	0.000793	0.00298	CcSEcCtD
Dolasetron—Fatigue—Vemurafenib—skin cancer	0.000792	0.00298	CcSEcCtD
Dolasetron—Constipation—Vemurafenib—skin cancer	0.000785	0.00295	CcSEcCtD
Dolasetron—Oedema—Imiquimod—skin cancer	0.000783	0.00295	CcSEcCtD
Dolasetron—Dysuria—Temozolomide—skin cancer	0.000772	0.0029	CcSEcCtD
Dolasetron—Shock—Imiquimod—skin cancer	0.00077	0.0029	CcSEcCtD
Dolasetron—Tachycardia—Imiquimod—skin cancer	0.000764	0.00287	CcSEcCtD
Dolasetron—Sepsis—Docetaxel—skin cancer	0.000759	0.00286	CcSEcCtD
Dolasetron—Hyperhidrosis—Imiquimod—skin cancer	0.000757	0.00285	CcSEcCtD
Dolasetron—Anorexia—Imiquimod—skin cancer	0.000746	0.00281	CcSEcCtD
Dolasetron—Pneumonia—Temozolomide—skin cancer	0.00074	0.00278	CcSEcCtD
Dolasetron—Phlebitis—Docetaxel—skin cancer	0.000737	0.00277	CcSEcCtD
Dolasetron—Thrombophlebitis—Docetaxel—skin cancer	0.000733	0.00276	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00073	0.00275	CcSEcCtD
Dolasetron—Flushing—Bleomycin—skin cancer	0.000727	0.00273	CcSEcCtD
Dolasetron—Body temperature increased—Vemurafenib—skin cancer	0.000726	0.00273	CcSEcCtD
Dolasetron—Stomatitis—Temozolomide—skin cancer	0.000717	0.0027	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000713	0.00268	CcSEcCtD
Dolasetron—Paraesthesia—Imiquimod—skin cancer	0.000703	0.00264	CcSEcCtD
Dolasetron—Chills—Bleomycin—skin cancer	0.000703	0.00264	CcSEcCtD
Dolasetron—Dyspnoea—Imiquimod—skin cancer	0.000698	0.00263	CcSEcCtD
Dolasetron—Somnolence—Imiquimod—skin cancer	0.000696	0.00262	CcSEcCtD
Dolasetron—Dyspepsia—Imiquimod—skin cancer	0.000689	0.00259	CcSEcCtD
Dolasetron—Pneumonia—Fluorouracil—skin cancer	0.000682	0.00256	CcSEcCtD
Dolasetron—Decreased appetite—Imiquimod—skin cancer	0.000681	0.00256	CcSEcCtD
Dolasetron—Flushing—Dactinomycin—skin cancer	0.000678	0.00255	CcSEcCtD
Dolasetron—Hypersensitivity—Vemurafenib—skin cancer	0.000676	0.00254	CcSEcCtD
Dolasetron—Fatigue—Imiquimod—skin cancer	0.000675	0.00254	CcSEcCtD
Dolasetron—Pain—Imiquimod—skin cancer	0.00067	0.00252	CcSEcCtD
Dolasetron—Acute coronary syndrome—Fluorouracil—skin cancer	0.000668	0.00251	CcSEcCtD
Dolasetron—Myocardial infarction—Fluorouracil—skin cancer	0.000664	0.0025	CcSEcCtD
Dolasetron—Stomatitis—Fluorouracil—skin cancer	0.000661	0.00249	CcSEcCtD
Dolasetron—Asthenia—Vemurafenib—skin cancer	0.000659	0.00248	CcSEcCtD
Dolasetron—Chills—Dactinomycin—skin cancer	0.000655	0.00246	CcSEcCtD
Dolasetron—Oedema peripheral—Temozolomide—skin cancer	0.000651	0.00245	CcSEcCtD
Dolasetron—Pruritus—Vemurafenib—skin cancer	0.00065	0.00244	CcSEcCtD
Dolasetron—Feeling abnormal—Imiquimod—skin cancer	0.000645	0.00243	CcSEcCtD
Dolasetron—Gastrointestinal pain—Imiquimod—skin cancer	0.00064	0.00241	CcSEcCtD
Dolasetron—Epistaxis—Fluorouracil—skin cancer	0.000639	0.00241	CcSEcCtD
Dolasetron—Visual impairment—Temozolomide—skin cancer	0.000636	0.00239	CcSEcCtD
Dolasetron—Ill-defined disorder—Bleomycin—skin cancer	0.000632	0.00238	CcSEcCtD
Dolasetron—Anaemia—Bleomycin—skin cancer	0.00063	0.00237	CcSEcCtD
Dolasetron—Diarrhoea—Vemurafenib—skin cancer	0.000628	0.00236	CcSEcCtD
Dolasetron—Urticaria—Imiquimod—skin cancer	0.000622	0.00234	CcSEcCtD
Dolasetron—Abdominal pain—Imiquimod—skin cancer	0.000619	0.00233	CcSEcCtD
Dolasetron—Body temperature increased—Imiquimod—skin cancer	0.000619	0.00233	CcSEcCtD
Dolasetron—Tinnitus—Temozolomide—skin cancer	0.000616	0.00232	CcSEcCtD
Dolasetron—Malaise—Bleomycin—skin cancer	0.000615	0.00231	CcSEcCtD
Dolasetron—Flushing—Temozolomide—skin cancer	0.000613	0.00231	CcSEcCtD
Dolasetron—Dizziness—Vemurafenib—skin cancer	0.000607	0.00228	CcSEcCtD
Dolasetron—Ataxia—Docetaxel—skin cancer	0.000597	0.00225	CcSEcCtD
Dolasetron—Cough—Bleomycin—skin cancer	0.000595	0.00224	CcSEcCtD
Dolasetron—Chills—Temozolomide—skin cancer	0.000593	0.00223	CcSEcCtD
Dolasetron—Dehydration—Docetaxel—skin cancer	0.00059	0.00222	CcSEcCtD
Dolasetron—Ill-defined disorder—Dactinomycin—skin cancer	0.00059	0.00222	CcSEcCtD
Dolasetron—Anaemia—Dactinomycin—skin cancer	0.000588	0.00221	CcSEcCtD
Dolasetron—Myalgia—Bleomycin—skin cancer	0.00058	0.00218	CcSEcCtD
Dolasetron—Chest pain—Bleomycin—skin cancer	0.00058	0.00218	CcSEcCtD
Dolasetron—Orthostatic hypotension—Docetaxel—skin cancer	0.00058	0.00218	CcSEcCtD
Dolasetron—Rash—Vemurafenib—skin cancer	0.000579	0.00218	CcSEcCtD
Dolasetron—Dermatitis—Vemurafenib—skin cancer	0.000578	0.00218	CcSEcCtD
Dolasetron—Hypersensitivity—Imiquimod—skin cancer	0.000577	0.00217	CcSEcCtD
Dolasetron—Headache—Vemurafenib—skin cancer	0.000575	0.00216	CcSEcCtD
Dolasetron—Discomfort—Bleomycin—skin cancer	0.000573	0.00216	CcSEcCtD
Dolasetron—Malaise—Dactinomycin—skin cancer	0.000573	0.00216	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000572	0.00215	CcSEcCtD
Dolasetron—Dysgeusia—Temozolomide—skin cancer	0.000563	0.00212	CcSEcCtD
Dolasetron—Asthenia—Imiquimod—skin cancer	0.000562	0.00211	CcSEcCtD
Dolasetron—Confusional state—Bleomycin—skin cancer	0.000561	0.00211	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00056	0.00211	CcSEcCtD
Dolasetron—Anaphylactic shock—Bleomycin—skin cancer	0.000556	0.00209	CcSEcCtD
Dolasetron—Oedema—Bleomycin—skin cancer	0.000556	0.00209	CcSEcCtD
Dolasetron—Pruritus—Imiquimod—skin cancer	0.000554	0.00208	CcSEcCtD
Dolasetron—Thrombocytopenia—Bleomycin—skin cancer	0.000545	0.00205	CcSEcCtD
Dolasetron—Arrhythmia—Fluorouracil—skin cancer	0.000544	0.00205	CcSEcCtD
Dolasetron—Myalgia—Dactinomycin—skin cancer	0.000541	0.00204	CcSEcCtD
Dolasetron—Bronchospasm—Docetaxel—skin cancer	0.00054	0.00203	CcSEcCtD
Dolasetron—Tremor—Temozolomide—skin cancer	0.000539	0.00203	CcSEcCtD
Dolasetron—Diarrhoea—Imiquimod—skin cancer	0.000536	0.00202	CcSEcCtD
Dolasetron—Discomfort—Dactinomycin—skin cancer	0.000535	0.00201	CcSEcCtD
Dolasetron—Ill-defined disorder—Temozolomide—skin cancer	0.000533	0.00201	CcSEcCtD
Dolasetron—Anaemia—Temozolomide—skin cancer	0.000531	0.002	CcSEcCtD
Dolasetron—Anorexia—Bleomycin—skin cancer	0.00053	0.00199	CcSEcCtD
Dolasetron—Agitation—Temozolomide—skin cancer	0.000528	0.00199	CcSEcCtD
Dolasetron—Angioedema—Temozolomide—skin cancer	0.000525	0.00198	CcSEcCtD
Dolasetron—Hypotension—Bleomycin—skin cancer	0.00052	0.00196	CcSEcCtD
Dolasetron—Oedema—Dactinomycin—skin cancer	0.000519	0.00195	CcSEcCtD
Dolasetron—Malaise—Temozolomide—skin cancer	0.000518	0.00195	CcSEcCtD
Dolasetron—Dizziness—Imiquimod—skin cancer	0.000518	0.00195	CcSEcCtD
Dolasetron—Vertigo—Temozolomide—skin cancer	0.000517	0.00194	CcSEcCtD
Dolasetron—Palpitations—Temozolomide—skin cancer	0.000508	0.00191	CcSEcCtD
Dolasetron—Thrombocytopenia—Dactinomycin—skin cancer	0.000508	0.00191	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000507	0.00191	CcSEcCtD
Dolasetron—Cough—Temozolomide—skin cancer	0.000502	0.00189	CcSEcCtD
Dolasetron—Paraesthesia—Bleomycin—skin cancer	0.000499	0.00188	CcSEcCtD
Dolasetron—Convulsion—Temozolomide—skin cancer	0.000498	0.00187	CcSEcCtD
Dolasetron—Hypertension—Temozolomide—skin cancer	0.000496	0.00187	CcSEcCtD
Dolasetron—Dyspnoea—Bleomycin—skin cancer	0.000496	0.00187	CcSEcCtD
Dolasetron—Anorexia—Dactinomycin—skin cancer	0.000495	0.00186	CcSEcCtD
Dolasetron—Rash—Imiquimod—skin cancer	0.000494	0.00186	CcSEcCtD
Dolasetron—Dermatitis—Imiquimod—skin cancer	0.000493	0.00186	CcSEcCtD
Dolasetron—Pneumonia—Docetaxel—skin cancer	0.000492	0.00185	CcSEcCtD
Dolasetron—Headache—Imiquimod—skin cancer	0.000491	0.00185	CcSEcCtD
Dolasetron—Anaemia—Fluorouracil—skin cancer	0.00049	0.00184	CcSEcCtD
Dolasetron—Myalgia—Temozolomide—skin cancer	0.000489	0.00184	CcSEcCtD
Dolasetron—Arthralgia—Temozolomide—skin cancer	0.000489	0.00184	CcSEcCtD
Dolasetron—Anxiety—Temozolomide—skin cancer	0.000488	0.00183	CcSEcCtD
Dolasetron—Discomfort—Temozolomide—skin cancer	0.000484	0.00182	CcSEcCtD
Dolasetron—Decreased appetite—Bleomycin—skin cancer	0.000484	0.00182	CcSEcCtD
Dolasetron—Acute coronary syndrome—Docetaxel—skin cancer	0.000482	0.00181	CcSEcCtD
Dolasetron—Myocardial infarction—Docetaxel—skin cancer	0.00048	0.0018	CcSEcCtD
Dolasetron—Dry mouth—Temozolomide—skin cancer	0.000479	0.0018	CcSEcCtD
Dolasetron—Jaundice—Docetaxel—skin cancer	0.000477	0.00179	CcSEcCtD
Dolasetron—Stomatitis—Docetaxel—skin cancer	0.000477	0.00179	CcSEcCtD
Dolasetron—Pain—Bleomycin—skin cancer	0.000476	0.00179	CcSEcCtD
Dolasetron—Confusional state—Temozolomide—skin cancer	0.000473	0.00178	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000473	0.00178	CcSEcCtD
Dolasetron—Oedema—Temozolomide—skin cancer	0.000469	0.00177	CcSEcCtD
Dolasetron—Anaphylactic shock—Temozolomide—skin cancer	0.000469	0.00177	CcSEcCtD
Dolasetron—Epistaxis—Docetaxel—skin cancer	0.000461	0.00174	CcSEcCtD
Dolasetron—Thrombocytopenia—Temozolomide—skin cancer	0.000459	0.00173	CcSEcCtD
Dolasetron—Convulsion—Fluorouracil—skin cancer	0.000459	0.00173	CcSEcCtD
Dolasetron—Feeling abnormal—Bleomycin—skin cancer	0.000458	0.00172	CcSEcCtD
Dolasetron—Hyperhidrosis—Temozolomide—skin cancer	0.000454	0.00171	CcSEcCtD
Dolasetron—Chest pain—Fluorouracil—skin cancer	0.000451	0.0017	CcSEcCtD
Dolasetron—Myalgia—Fluorouracil—skin cancer	0.000451	0.0017	CcSEcCtD
Dolasetron—Decreased appetite—Dactinomycin—skin cancer	0.000451	0.0017	CcSEcCtD
Dolasetron—Fatigue—Dactinomycin—skin cancer	0.000447	0.00168	CcSEcCtD
Dolasetron—Anorexia—Temozolomide—skin cancer	0.000447	0.00168	CcSEcCtD
Dolasetron—Discomfort—Fluorouracil—skin cancer	0.000446	0.00168	CcSEcCtD
Dolasetron—Pain—Dactinomycin—skin cancer	0.000444	0.00167	CcSEcCtD
Dolasetron—Urticaria—Bleomycin—skin cancer	0.000442	0.00166	CcSEcCtD
Dolasetron—Body temperature increased—Bleomycin—skin cancer	0.00044	0.00165	CcSEcCtD
Dolasetron—Confusional state—Fluorouracil—skin cancer	0.000436	0.00164	CcSEcCtD
Dolasetron—Oedema peripheral—Docetaxel—skin cancer	0.000433	0.00163	CcSEcCtD
Dolasetron—Oedema—Fluorouracil—skin cancer	0.000432	0.00163	CcSEcCtD
Dolasetron—Anaphylactic shock—Fluorouracil—skin cancer	0.000432	0.00163	CcSEcCtD
Dolasetron—Feeling abnormal—Dactinomycin—skin cancer	0.000428	0.00161	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000428	0.00161	CcSEcCtD
Dolasetron—Gastrointestinal pain—Dactinomycin—skin cancer	0.000424	0.0016	CcSEcCtD
Dolasetron—Thrombocytopenia—Fluorouracil—skin cancer	0.000423	0.00159	CcSEcCtD
Dolasetron—Visual impairment—Docetaxel—skin cancer	0.000423	0.00159	CcSEcCtD
Dolasetron—Tachycardia—Fluorouracil—skin cancer	0.000422	0.00159	CcSEcCtD
Dolasetron—Paraesthesia—Temozolomide—skin cancer	0.000421	0.00159	CcSEcCtD
Dolasetron—Dyspnoea—Temozolomide—skin cancer	0.000418	0.00157	CcSEcCtD
Dolasetron—Somnolence—Temozolomide—skin cancer	0.000417	0.00157	CcSEcCtD
Dolasetron—Dyspepsia—Temozolomide—skin cancer	0.000413	0.00155	CcSEcCtD
Dolasetron—Anorexia—Fluorouracil—skin cancer	0.000412	0.00155	CcSEcCtD
Dolasetron—Abdominal pain—Dactinomycin—skin cancer	0.00041	0.00154	CcSEcCtD
Dolasetron—Body temperature increased—Dactinomycin—skin cancer	0.00041	0.00154	CcSEcCtD
Dolasetron—Hypersensitivity—Bleomycin—skin cancer	0.00041	0.00154	CcSEcCtD
Dolasetron—Decreased appetite—Temozolomide—skin cancer	0.000408	0.00153	CcSEcCtD
Dolasetron—Flushing—Docetaxel—skin cancer	0.000408	0.00153	CcSEcCtD
Dolasetron—Fatigue—Temozolomide—skin cancer	0.000405	0.00152	CcSEcCtD
Dolasetron—Hypotension—Fluorouracil—skin cancer	0.000404	0.00152	CcSEcCtD
Dolasetron—Constipation—Temozolomide—skin cancer	0.000401	0.00151	CcSEcCtD
Dolasetron—Pain—Temozolomide—skin cancer	0.000401	0.00151	CcSEcCtD
Dolasetron—Asthenia—Bleomycin—skin cancer	0.000399	0.0015	CcSEcCtD
Dolasetron—Chills—Docetaxel—skin cancer	0.000394	0.00148	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000394	0.00148	CcSEcCtD
Dolasetron—Pruritus—Bleomycin—skin cancer	0.000394	0.00148	CcSEcCtD
Dolasetron—Arrhythmia—Docetaxel—skin cancer	0.000392	0.00148	CcSEcCtD
Dolasetron—Paraesthesia—Fluorouracil—skin cancer	0.000388	0.00146	CcSEcCtD
Dolasetron—Feeling abnormal—Temozolomide—skin cancer	0.000387	0.00145	CcSEcCtD
Dolasetron—Dyspnoea—Fluorouracil—skin cancer	0.000385	0.00145	CcSEcCtD
Dolasetron—Somnolence—Fluorouracil—skin cancer	0.000384	0.00145	CcSEcCtD
Dolasetron—Gastrointestinal pain—Temozolomide—skin cancer	0.000384	0.00144	CcSEcCtD
Dolasetron—Hypersensitivity—Dactinomycin—skin cancer	0.000382	0.00144	CcSEcCtD
Dolasetron—Dyspepsia—Fluorouracil—skin cancer	0.000381	0.00143	CcSEcCtD
Dolasetron—Decreased appetite—Fluorouracil—skin cancer	0.000376	0.00141	CcSEcCtD
Dolasetron—Dysgeusia—Docetaxel—skin cancer	0.000374	0.00141	CcSEcCtD
Dolasetron—Urticaria—Temozolomide—skin cancer	0.000373	0.0014	CcSEcCtD
Dolasetron—Asthenia—Dactinomycin—skin cancer	0.000372	0.0014	CcSEcCtD
Dolasetron—Abdominal pain—Temozolomide—skin cancer	0.000371	0.0014	CcSEcCtD
Dolasetron—Body temperature increased—Temozolomide—skin cancer	0.000371	0.0014	CcSEcCtD
Dolasetron—Pain—Fluorouracil—skin cancer	0.00037	0.00139	CcSEcCtD
Dolasetron—Feeling abnormal—Fluorouracil—skin cancer	0.000356	0.00134	CcSEcCtD
Dolasetron—Diarrhoea—Dactinomycin—skin cancer	0.000355	0.00134	CcSEcCtD
Dolasetron—Anaemia—Docetaxel—skin cancer	0.000353	0.00133	CcSEcCtD
Dolasetron—Rash—Bleomycin—skin cancer	0.000351	0.00132	CcSEcCtD
Dolasetron—Dermatitis—Bleomycin—skin cancer	0.00035	0.00132	CcSEcCtD
Dolasetron—Hypersensitivity—Temozolomide—skin cancer	0.000346	0.0013	CcSEcCtD
Dolasetron—Urticaria—Fluorouracil—skin cancer	0.000343	0.00129	CcSEcCtD
Dolasetron—Syncope—Docetaxel—skin cancer	0.000343	0.00129	CcSEcCtD
Dolasetron—Body temperature increased—Fluorouracil—skin cancer	0.000342	0.00129	CcSEcCtD
Dolasetron—Palpitations—Docetaxel—skin cancer	0.000338	0.00127	CcSEcCtD
Dolasetron—Asthenia—Temozolomide—skin cancer	0.000337	0.00127	CcSEcCtD
Dolasetron—Loss of consciousness—Docetaxel—skin cancer	0.000336	0.00126	CcSEcCtD
Dolasetron—Cough—Docetaxel—skin cancer	0.000334	0.00126	CcSEcCtD
Dolasetron—Pruritus—Temozolomide—skin cancer	0.000332	0.00125	CcSEcCtD
Dolasetron—Convulsion—Docetaxel—skin cancer	0.000331	0.00125	CcSEcCtD
Dolasetron—Hypertension—Docetaxel—skin cancer	0.00033	0.00124	CcSEcCtD
Dolasetron—Rash—Dactinomycin—skin cancer	0.000327	0.00123	CcSEcCtD
Dolasetron—Arthralgia—Docetaxel—skin cancer	0.000326	0.00122	CcSEcCtD
Dolasetron—Chest pain—Docetaxel—skin cancer	0.000326	0.00122	CcSEcCtD
Dolasetron—Myalgia—Docetaxel—skin cancer	0.000326	0.00122	CcSEcCtD
Dolasetron—Diarrhoea—Temozolomide—skin cancer	0.000321	0.00121	CcSEcCtD
Dolasetron—Hypersensitivity—Fluorouracil—skin cancer	0.000319	0.0012	CcSEcCtD
Dolasetron—Dry mouth—Docetaxel—skin cancer	0.000318	0.0012	CcSEcCtD
Dolasetron—Confusional state—Docetaxel—skin cancer	0.000315	0.00118	CcSEcCtD
Dolasetron—Anaphylactic shock—Docetaxel—skin cancer	0.000312	0.00117	CcSEcCtD
Dolasetron—Oedema—Docetaxel—skin cancer	0.000312	0.00117	CcSEcCtD
Dolasetron—Dizziness—Temozolomide—skin cancer	0.00031	0.00117	CcSEcCtD
Dolasetron—Shock—Docetaxel—skin cancer	0.000307	0.00115	CcSEcCtD
Dolasetron—Pruritus—Fluorouracil—skin cancer	0.000306	0.00115	CcSEcCtD
Dolasetron—Thrombocytopenia—Docetaxel—skin cancer	0.000306	0.00115	CcSEcCtD
Dolasetron—Tachycardia—Docetaxel—skin cancer	0.000305	0.00115	CcSEcCtD
Dolasetron—Anorexia—Docetaxel—skin cancer	0.000297	0.00112	CcSEcCtD
Dolasetron—Rash—Temozolomide—skin cancer	0.000296	0.00111	CcSEcCtD
Dolasetron—Diarrhoea—Fluorouracil—skin cancer	0.000296	0.00111	CcSEcCtD
Dolasetron—Dermatitis—Temozolomide—skin cancer	0.000296	0.00111	CcSEcCtD
Dolasetron—Headache—Temozolomide—skin cancer	0.000294	0.00111	CcSEcCtD
Dolasetron—Hypotension—Docetaxel—skin cancer	0.000292	0.0011	CcSEcCtD
Dolasetron—Dizziness—Fluorouracil—skin cancer	0.000286	0.00108	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000284	0.00107	CcSEcCtD
Dolasetron—Paraesthesia—Docetaxel—skin cancer	0.00028	0.00105	CcSEcCtD
Dolasetron—Dyspnoea—Docetaxel—skin cancer	0.000278	0.00105	CcSEcCtD
Dolasetron—Somnolence—Docetaxel—skin cancer	0.000277	0.00104	CcSEcCtD
Dolasetron—Dyspepsia—Docetaxel—skin cancer	0.000275	0.00103	CcSEcCtD
Dolasetron—Rash—Fluorouracil—skin cancer	0.000273	0.00103	CcSEcCtD
Dolasetron—Dermatitis—Fluorouracil—skin cancer	0.000272	0.00102	CcSEcCtD
Dolasetron—Decreased appetite—Docetaxel—skin cancer	0.000271	0.00102	CcSEcCtD
Dolasetron—Headache—Fluorouracil—skin cancer	0.000271	0.00102	CcSEcCtD
Dolasetron—Fatigue—Docetaxel—skin cancer	0.000269	0.00101	CcSEcCtD
Dolasetron—Pain—Docetaxel—skin cancer	0.000267	0.001	CcSEcCtD
Dolasetron—Constipation—Docetaxel—skin cancer	0.000267	0.001	CcSEcCtD
Dolasetron—Feeling abnormal—Docetaxel—skin cancer	0.000257	0.000967	CcSEcCtD
Dolasetron—Gastrointestinal pain—Docetaxel—skin cancer	0.000255	0.00096	CcSEcCtD
Dolasetron—Abdominal pain—Docetaxel—skin cancer	0.000247	0.000928	CcSEcCtD
Dolasetron—Body temperature increased—Docetaxel—skin cancer	0.000247	0.000928	CcSEcCtD
Dolasetron—Hypersensitivity—Docetaxel—skin cancer	0.00023	0.000865	CcSEcCtD
Dolasetron—Asthenia—Docetaxel—skin cancer	0.000224	0.000842	CcSEcCtD
Dolasetron—Pruritus—Docetaxel—skin cancer	0.000221	0.000831	CcSEcCtD
Dolasetron—Diarrhoea—Docetaxel—skin cancer	0.000214	0.000803	CcSEcCtD
Dolasetron—Dizziness—Docetaxel—skin cancer	0.000206	0.000776	CcSEcCtD
Dolasetron—Rash—Docetaxel—skin cancer	0.000197	0.00074	CcSEcCtD
Dolasetron—Dermatitis—Docetaxel—skin cancer	0.000197	0.000739	CcSEcCtD
Dolasetron—Headache—Docetaxel—skin cancer	0.000195	0.000735	CcSEcCtD
